Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Lambert

Showing results (481-490 of 518) with videos related to

Pageof 52
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2021
Tenofovir Alafenamide Plasma Concentrations Are Reduced in Pregnant Women Living With Human Immunodeficiency Virus (HIV): Data From the PANNA NetworkVera E Bukkems, Coca Necsoi, Carmen Hidalgo Tenorio, et al.
Frontiers in Immunology|October 9, 2024
Signal peptide exchange alters HIV-1 envelope antigenicity and immunogenicityChitra Upadhyay, Priyanka Rao, Mohammad Amin Behzadi, et al.
Nature|April 21, 2022
Chemotaxis shapes the microscale organization of the ocean's microbiomeJean-Baptiste Raina, Bennett S Lambert, Donovan H Parks, et al.
BMC Infectious Diseases|November 17, 2023
Impact of vaccination and variants of concern on long COVID clinical phenotypesGrace Kenny, Kathleen McCann, Conor O'Brien, et al.
The Journal of Antimicrobial Chemotherapy|November 30, 2019
HepCare Europe: a service innovation project. HepCheck: enhancing HCV identification and linkage to care for vulnerable populations through intensified outreach screening. A prospective multisite feasibility studySuzanne Barror, Gordana Avramovic, Cristiana Oprea, et al.
The Journal of Antimicrobial Chemotherapy|December 26, 2015
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ARTS Lambert-Niclot, E C George, A Pozniak, et al.
The Journal of Infectious Diseases|September 9, 1999
Immunization with envelope MN rgp120 vaccine in human immunodeficiency virus-infected pregnant womenP F Wright, J S Lambert, G J Gorse, et al.
The Journal of Infectious Diseases|February 1, 1997
Safety and pharmacokinetics of hyperimmune anti-human immunodeficiency virus (HIV) immunoglobulin administered to HIV-infected pregnant women and their newborns. Pediatric AIDS Clinical Trials Group Protocol 185 Pharmacokinetic Study GroupJ S Lambert, L M Mofenson, C V Fletcher, et al.
Future Microbiology|September 4, 2024
Combined bictegravir, emtricitabine and tenofovir alafenamide for treating people with HIV: a plain language summary of the BICSTaR study up to 1 yearStefan Esser, Alexy Inciarte, Itzchak Levy, et al.
Journal of Clinical Microbiology|March 21, 1998
Antigenic diversity of hepatitis B virus strains of genotype F in Amerindians and other population groups from VenezuelaL Blitz, F H Pujol, P D Swenson, et al.
Pageof 52

Showing results (481-490 of 518) with videos related to

Sort By:
Pageof 52
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2021
Tenofovir Alafenamide Plasma Concentrations Are Reduced in Pregnant Women Living With Human Immunodeficiency Virus (HIV): Data From the PANNA NetworkVera E Bukkems, Coca Necsoi, Carmen Hidalgo Tenorio, et al.
Frontiers in Immunology|October 9, 2024
Signal peptide exchange alters HIV-1 envelope antigenicity and immunogenicityChitra Upadhyay, Priyanka Rao, Mohammad Amin Behzadi, et al.
Nature|April 21, 2022
Chemotaxis shapes the microscale organization of the ocean's microbiomeJean-Baptiste Raina, Bennett S Lambert, Donovan H Parks, et al.
BMC Infectious Diseases|November 17, 2023
Impact of vaccination and variants of concern on long COVID clinical phenotypesGrace Kenny, Kathleen McCann, Conor O'Brien, et al.
The Journal of Antimicrobial Chemotherapy|November 30, 2019
HepCare Europe: a service innovation project. HepCheck: enhancing HCV identification and linkage to care for vulnerable populations through intensified outreach screening. A prospective multisite feasibility studySuzanne Barror, Gordana Avramovic, Cristiana Oprea, et al.
The Journal of Antimicrobial Chemotherapy|December 26, 2015
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ARTS Lambert-Niclot, E C George, A Pozniak, et al.
The Journal of Infectious Diseases|September 9, 1999
Immunization with envelope MN rgp120 vaccine in human immunodeficiency virus-infected pregnant womenP F Wright, J S Lambert, G J Gorse, et al.
The Journal of Infectious Diseases|February 1, 1997
Safety and pharmacokinetics of hyperimmune anti-human immunodeficiency virus (HIV) immunoglobulin administered to HIV-infected pregnant women and their newborns. Pediatric AIDS Clinical Trials Group Protocol 185 Pharmacokinetic Study GroupJ S Lambert, L M Mofenson, C V Fletcher, et al.
Future Microbiology|September 4, 2024
Combined bictegravir, emtricitabine and tenofovir alafenamide for treating people with HIV: a plain language summary of the BICSTaR study up to 1 yearStefan Esser, Alexy Inciarte, Itzchak Levy, et al.
Journal of Clinical Microbiology|March 21, 1998
Antigenic diversity of hepatitis B virus strains of genotype F in Amerindians and other population groups from VenezuelaL Blitz, F H Pujol, P D Swenson, et al.
Pageof 52